Sub Banner Image

Aspen Surges on Plan to Sell Generic Obesity Drugs From 2026

Markets

Janice Kew

·

March 3, 2025

·

Bloomberg

Aspen Pharmacare Holdings Ltd. rose by the most in two years after Africa’s largest drugmaker said it expects to generate revenue from its own generic versions of diabetes and obesity drugs from as early as 2026.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.